Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

NCT01110785 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: simvastatin
OTHER: laboratory biomarker analysis

Sponsor

Leiden University Medical Center